4
累計(jì)需求單數(shù)
￥295.0
累計(jì)需求金額
0
違規(guī)次數(shù)
求購(gòu)文獻(xiàn)數(shù)篇
懸賞
已托管
￥110.00
￥110.00
- 發(fā)布需求
- 藥智客交稿
- 任務(wù)主選稿中
- 驗(yàn)收與付款
已完成
- 交易模式：
- 單人中標(biāo)
- 賞金分配：
- 一人獨(dú)享賞金，￥93.5
具體要求：
1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels
2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components
3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage
4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors
5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure
6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion
7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema
8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites
9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease
10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement
11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print]
12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print]
13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form
14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines
15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing
16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms
17. On the hydrolytic behavior of tinidazole, metronidazole, and ornidazole
18. Novel topical microbicidal compositionsBy Mody, Shirish Bhagwanlal; Doshi, Madhukant Mansukhlal; Joshi, Milind Dattatraya
19. Determination of ornidazole and its main metabolites in biological fluidsBy Heizmann, P.; Geschke, R.; Zinapold, K
20. Reactions of nitroimidazoles with free radicals--enhancement of reaction by u.v. irradiation
21. 25.RJPBCS 5（2014）1637-1644
22. J. AOAC Int. 96（2013）37-41
2018-12-29 11:44
有0條新稿件，點(diǎn)擊看看
當(dāng)前為付費(fèi)需求，賞金分配方式：一人獨(dú)享賞金。
任務(wù)主在眾多備選稿件中選擇最滿意的稿件，支付賞金。
托管賞金，保障各方權(quán)益：
㚱
任務(wù)主把所發(fā)需求的懸賞金托管到藥智網(wǎng)指定賬戶，以激發(fā)眾多藥智客的參與熱情，保障任務(wù)主盡快征集到滿意稿件；
同時(shí)，賞金托管也是為了保障參與挑戰(zhàn)的藥智客的正當(dāng)權(quán)益。
交易流程：
流程說(shuō)明：
㗊
發(fā)布需求
點(diǎn)擊“發(fā)布需求”按鈕，按照流程引導(dǎo)，將需求詳情、具體要求描述清楚，發(fā)布到藥智網(wǎng)的藥智匯平臺(tái)。
㑦
托管賞金
為征集到滿意稿件，任務(wù)主須做好“賞金預(yù)算”，并將賞金托管到藥智網(wǎng)指定賬戶，打消藥智客的顧慮，激勵(lì)藥智客積極參與需求挑戰(zhàn)。
㔆
藥智客參與
任務(wù)主托管賞金后，所發(fā)布的需求顯示“賞金已托管”字樣。只有托管了懸賞金的需求，能夠鼓舞眾多的藥智客參與，獲取到滿意的稿件！
㖇
選擇滿意稿件
任務(wù)主在眾多參與者提交的稿件中，選擇符合任務(wù)主需求的稿件。再通過(guò)互動(dòng)，選擇任務(wù)主最滿意的稿件，并確定其為中標(biāo)稿件。
㚱
驗(yàn)收與付款
中標(biāo)稿件提交任務(wù)主驗(yàn)收。任務(wù)主在驗(yàn)收/驗(yàn)證期內(nèi)，完成驗(yàn)收/驗(yàn)證工作。對(duì)合格稿件，通知藥智網(wǎng)支付傭金。
㕭
評(píng)價(jià)
雙方可以針對(duì)本次交易各自的表現(xiàn)進(jìn)行評(píng)價(jià)，評(píng)價(jià)結(jié)果將影響各自的信用度和能力值。
消費(fèi)者維權(quán)流程：
類似的需求
加載數(shù)據(jù)中...
該需求者還有這些需求
加載數(shù)據(jù)中...
推薦需求
加載數(shù)據(jù)中...
